Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
66,549,683
-
Shares change
-
-523,769
-
Total reported value, excl. options
-
$4,154,048,742
-
Value change
-
-$66,618,101
-
Put/Call ratio
-
66.8%
-
Number of buys
-
133
-
Number of sells
-
-148
-
Price
-
$62.43
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2021
347 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q3 2021.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,549,683 shares
of 138,764,349 outstanding shares and own 47.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11,941,845 shares), VANGUARD GROUP INC (9,643,916 shares), STATE STREET CORP (3,931,168 shares), JOHNSON & JOHNSON (3,260,869 shares), JPMORGAN CHASE & CO (2,839,242 shares), Invesco Ltd. (2,313,443 shares), GEODE CAPITAL MANAGEMENT, LLC (1,790,377 shares), CREDIT SUISSE AG/ (1,448,514 shares), NORTHERN TRUST CORP (1,443,951 shares), and FMR LLC (1,331,123 shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.